Is this the future of cancer funding?

Posted 5 February 2025 AM

Not-for-profit genomics pioneer, Omico, has formally proposed a first of its kind shared funding model between private and public sectors to turn groundbreaking cancer treatments into affordable, routine clinical care for Australians diagnosed with rare and challenging cancers.

The proposed Precision Oncology Health System Incubator (PrO-HSI) sets out a strategic investment pathway with multi-sector funding using established policy and infrastructure frameworks, to integrate advanced therapies into contemporary cancer care without overwhelming public resources amid a diminishing taxpayer base and ageing population.

To see the whole article, please login